It is Accepted That Adenoid Hypertrophy is Related to Otitis Media With Effusion Incidence. Better Understanding of the Correlation Between the Relative Size of AH and the Incidence of Persistent OME May Provide Evidence to Support a More Standardized Approach to the Diagnosis and Treatment of OME.

Launched by ASSIUT UNIVERSITY · Nov 3, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to better understand the relationship between the size of adenoid hypertrophy (which is when the adenoids, located in the back of the throat, become enlarged) and the occurrence of fluid build-up in the middle ear, known as otitis media with effusion (OME). The goal is to gather information that could help create a more consistent way to diagnose and treat OME in children.

To be eligible for this study, participants must be children under 16 years old who have both adenoid hypertrophy and OME. Unfortunately, children with certain medical conditions, like those affecting the palate or other serious health issues, cannot participate. If your child is chosen for the study, they will help researchers learn more about how these two conditions are connected. This could lead to better treatment options in the future for many kids dealing with similar issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children (until age of 16 years old).
• • Patients with adenoid hypertrophy.
• • Patients with OME.
• Exclusion Criteria:
• • Children known to have cleft palate, submucous cleft palate or other medical problems causing velopharyngeal insufficiency.
• • Down's syndrome, septal deviation, primary ciliary dyskinesia (Kartagener's syndrome), previous head or ear trauma, or previous myringotomy with ventilation tube insertion
• • Systemic medical problems interfering with surgery.
• • Refusal of parents to participate.
• • Craniofacial abnormalities.